The role of post-translational modifications of huntingtin in the pathogenesis of Huntington's disease

Neuroscience Bulletin

Volumn 26, Issue 2, 2010, Pages 153-162

  Wang, Yan ^a   Lin, Fang ^a   Qin, Zheng Hong ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

Acetylation; Huntingtin; Huntington's disease; Modification; Palmitoylation; Phosphorylation; SUMOylation

Indexed keywords

CYCLIN DEPENDENT KINASE 5; HUNTINGTIN; HUNTINGTIN 14; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; SERUM AND GLUCOCORTICOID REGULATED KINASE; UNCLASSIFIED DRUG;

ACETYLATION; CELL DEATH; DOWN REGULATION; GENE OVEREXPRESSION; HUNTINGTON CHOREA; NEUROTOXICITY; NONHUMAN; PALMITOYLATION; PATHOGENESIS; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; REGULATORY MECHANISM; SHORT SURVEY; SUMOYLATION;

ANIMALS; HUMANS; HUNTINGTON DISEASE; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 77953496589     PISSN: 16737067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12264-010-1118-6     Document Type: Short Survey

References (66)

1. Steffan JS, Agrawal N, Pallos J, Rockabrand E, Trotman LC, Slepko N, et al. SUMO modification of Huntingtin and Huntington's disease pathology. Science 2004, 304 (5667): 100-104.
2. Wellington CL, Singaraja R, Ellerby L, Savill J, Roy S, Leavitt B, et al. Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J Biol Chem 2000, 275 (26): 19831-19838.
3. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997, 277 (5334): 1990-1993.
4. Kegel KB, Sapp E, Yoder J, Cuiffo B, Sobin L, Kim YJ, et al. Huntingtin associates with acidic phospholipids at the plasma membrane. J Biol Chem 2005, 280 (43): 36464-36473.
5. Humbert S, Bryson EA, Cordelieres FP, Connors NC, Datta SR, Finkbeiner S, et al. The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev Cell 2002, 2 (6): 831-837.
6. Warby SC, Chan EY, Metzler M, Gan L, Singaraja RR, Crocker SF, et al. Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivo. Hum Mol Genet 2005, 14 (11): 1569-1577.
7. Dorval V, Fraser PE. SUMO on the road to neurodegeneration. Biochim Biophys Acta 2007, 1773 (6): 694-706.
8. Dohmen RJ. SUMO protein modification. Biochim Biophys Acta 2004, 1695 (1-3): 113-131.
9. Su HL, Li SS. Molecular features of human ubiquitin-like SUMO genes and their encoded proteins. Gene 2002, 296 (1-2): 65-73.
10. Hay RT. SUMO: a history of modification. Mol Cell 2005, 18 (1): 1-12.
11. Bernier-Villamor V, Sampson DA, Matunis MJ, Lima CD. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin- conjugating enzyme Ubc9 and RanGAP1. Cell 2002, 108 (3): 345-356.
12. Johnson ES. Protein modification by SUMO. Annu Rev Biochem 2004, 73: 355-382.
13. Mahajan R, Delphin C, Guan T, Gerace L, Melchior F. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 1997, 88 (1): 97-107.
14. Matunis MJ, Coutavas E, Blobel G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol 1996, 135 (6 Pt 1): 1457-1470.
15. Cheng TS, Chang LK, Howng SL, Lu PJ, Lee CI, Hong YR. SUMO-1 modification of centrosomal protein hNinein promotes hNinein nuclear localization. Life Sci 2006, 78 (10): 1114-1120.
16. Gill G. Something about SUMO inhibits transcription. Curr Opin Genet Dev 2005, 15 (5): 536-541.
17. Barford D, Das AK, Egloff MP. The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annu Rev Biophys Biomol Struct 1998, 27: 133-164.
18. Cozzone AJ. Protein phosphorylation in prokaryotes. Annu Rev Microbiol 1988, 42: 97-125.
19. Tozser J, Bagossi P, Zahuczky G, Specht SI, Majerova E, Copeland TD. Effect of caspase cleavage-site phosphorylation on proteolysis. Biochem J 2003, 372 (Pt 1): 137-143.
20. Poon IK, Jans DA. Regulation of nuclear transport: central role in development and transformation? Traffic 2005, 6 (3): 173-186.
21. Colin E, Regulier E, Perrin V, Durr A, Brice A, Aebischer P, et al. Akt is altered in an animal model of Huntington's disease and in patients. Eur J Neurosci 2005, 21 (6): 1478-1488.
22. Klumpp S, Krieglstein J. Phosphorylation and dephosphorylation of histidine residues in proteins. Eur J Biochem 2002, 269 (4): 1067-1071.
23. Linder ME, Middleton P, Hepler JR, Taussig R, Gilman AG, Mumby SM. Lipid modifications of G proteins: alpha subunits are palmitoylated. Proc Natl Acad Sci U S A 1993, 90 (8): 3675-3679.
24. Sadoul K, Boyault C, Pabion M, Khochbin S. Regulation of protein turnover by acetyltransferases and deacetylases. Biochimie 2008, 90 (2): 306-312.
25. Glozak MA, Sengupta N, Zhang X, Seto E. Acetylation and deacetylation of non-histone proteins. Gene 2005, 363: 15-23.
26. Subramaniam S, Sixt KM, Barrow R, Snyder SH. Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 2009, 324 (5932): 1327-1330.
27. Yasuda S, Inoue K, Hirabayashi M, Higashiyama H, Yamamoto Y, Fuyuhiro H, et al. Triggering of neuronal cell death by accumulation of activated SEK1 on nuclear polyglutamine aggregations in PML bodies. Genes Cells 1999, 4 (12): 743-756.
28. Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, et al. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A 2000, 97 (12): 6763-6768.
29. Shalizi A, Gaudilliere B, Yuan Z, Stegmuller J, Shirogane T, Ge Q, et al. A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation. Science 2006, 311 (5763): 1012-1017.
30. Luo S, Vacher C, Davies JE, Rubinsztein DC. Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity. J Cell Biol 2005, 169 (4): 647-656.
31. Colin E, Zala D, Liot G, Rangone H, Borrell-Pages M, Li XJ, et al. Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons. EMBO J 2008, 27 (15): 2124-2134.
32. Pardo R, Colin E, Regulier E, Aebischer P, Deglon N, Humbert S, et al. Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421. J Neurosci 2006, 26 (5): 1635-1645.
33. Rangone H, Poizat G, Troncoso J, Ross CA, MacDonald ME, Saudou F, et al. The serum- and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtin. Eur J Neurosci 2004, 19 (2): 273-279.
34. Warby SC, Doty CN, Graham RK, Shively J, Singaraja RR, Hayden MR. Phosphorylation of huntingtin reduces the accumulation of its nuclear fragments. Mol Cell Neurosci 2009, 40 (2): 121-127.
35. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. PI3K/Akt and apoptosis: size matters. Oncogene 2003, 22 (56): 8983-8998.
36. Zala D, Colin E, Rangone H, Liot G, Humbert S, Saudou F. Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons. Hum Mol Genet 2008, 17 (24): 3837-3846.
37. Li H, Li SH, Yu ZX, Shelbourne P, Li XJ. Huntingtin aggregateassociated axonal degeneration is an early pathological event in Huntington's disease mice. J Neurosci 2001, 21 (21): 8473-8481.
38. Lee WC, Yoshihara M, Littleton JT. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal trans port in a Drosophila model of Huntington's disease. Proc Natl Acad Sci U S A 2004, 101 (9): 3224-3229.
39. Block-Galarza J, Chase KO, Sapp E, Vaughn KT, Vallee RB, DiFiglia M, et al. Fast transport and retrograde movement of huntingtin and HAP 1 in axons. Neuroreport 1997, 8 (9-10): 2247-2251.
40. Gunawardena S, Her LS, Brusch RG, Laymon RA, Niesman IR, Gordesky-Gold B, et al. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 2003, 40 (1): 25-40.
41. Fei E, Jia N, Zhang T, Ma X, Wang H, Liu C, et al. Phosphorylation of ataxin-3 by glycogen synthase kinase 3beta at serine 256 regulates the aggregation of ataxin-3. Biochem Biophys Res Commun 2007, 357 (2): 487-492.
42. Anne SL, Saudou F, Humbert S. Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons. J Neurosci 2007, 27 (27): 7318-7328.
43. Cruz JC, Tsai LH. Cdk5 deregulation in the pathogenesis of Alzheimer's disease. Trends Mol Med 2004, 10 (9): 452-458.
44. Kaminosono S, Saito T, Oyama F, Ohshima T, Asada A, Nagai Y, et al. Suppression of mutant Huntingtin aggregate formation by Cdk5/p35 through the effect on microtubule stability. J Neurosci 2008, 28 (35): 8747-8755.
45. El-Husseini AE, Craven SE, Chetkovich DM, Firestein BL, Schnell E, Aoki C, et al. Dual palmitoylation of PSD-95 mediates its vesiculotubular sorting, postsynaptic targeting, and ion channel clustering. J Cell Biol 2000, 148 (1): 159-172.
46. El-Husseini Ael D, Bredt DS. Protein palmitoylation: a regulator of neuronal development and function. Nat Rev Neurosci 2002, 3 (10): 791-802.
47. Huang K, El-Husseini A. Modulation of neuronal protein trafficking and function by palmitoylation. Curr Opin Neurobiol 2005, 15 (5): 527-535.
48. Singaraja RR, Hadano S, Metzler M, Givan S, Wellington CL, Warby S, et al. HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis. Hum Mol Genet 2002, 11 (23): 2815-2828.
49. Huang K, Yanai A, Kang R, Arstikaitis P, Singaraja RR, Metzler M, et al. Huntingtin-interacting protein HIP14 is a palmitoyl transferase involved in palmitoylation and trafficking of multiple neuronal proteins. Neuron 2004, 44 (6): 977-986.
50. Yanai A, Huang K, Kang R, Singaraja RR, Arstikaitis P, Gan L, et al. Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function. Nat Neurosci 2006, 9 (6): 824-831.
51. Jeong H, Then F, Melia TJ, Jr., Mazzulli JR, Cui L, Savas JN, et al. Acetylation targets mutant huntingtin to autophagosomes for degradation. Cell 2009, 137 (1): 60-72.
52. Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, et al. Histone deacetylase inhibitors arrest polyglutaminedependent neurodegeneration in Drosophila. Nature 2001, 413 (6857): 739-743.
53. Bannister AJ, Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature 1996, 384 (6610): 641-643.
54. Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 2007, 8 (11): 931-937.
55. Cuervo AM. Autophagy: many paths to the same end. Mol Cell Biochem 2004, 263 (1-2): 55-72.
56. Lievens JC, Iche M, Laval M, Faivre-Sarrailh C, Birman S. AKTsensitive or insensitive pathways of toxicity in glial cells and neurons in Drosophila models of Huntington's disease. Hum Mol Genet 2008, 17 (6): 882-894.
57. Nixon RA. Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases. Neurobiol Aging 2005, 26 (3): 373-382.
58. Nagaoka U, Kim K, Jana NR, Doi H, Maruyama M, Mitsui K, et al. Increased expression of p62 in expanded polyglutamine-expressing cells and its association with polyglutamine inclusions. J Neurochem 2004, 91 (1): 57-68.
59. Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 2005, 171 (4): 603-614.
60. Kouzarides T. Acetylation: a regulatory modification to rival phosphorylation? EMBO J 2000, 19 (6): 1176-1179.
61. Kegel KB, Meloni AR, Yi Y, Kim YJ, Doyle E, Cuiffo BG, et al. Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. J Biol Chem 2002, 277 (9): 7466-7476.
62. Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 2004, 36 (6): 585-595.
63. Yamamoto A, Cremona ML, Rothman JE. Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway. J Cell Biol 2006, 172 (5): 719-731.
64. Schilling B, Gafni J, Torcassi C, Cong X, Row RH, LaFevre-Bernt MA, et al. Huntingtin phosphorylation sites mapped by mass spectrometry. Modulation of cleavage and toxicity. J Biol Chem 2006, 281 (33): 23686-23697.
65. Pennuto M, Palazzolo I, Poletti A. Post-translational modifications of expanded polyglutamine proteins: impact on neurotoxicity. Hum Mol Genet 2009, 18 (R1): R40-47.
66. Joyoti B. Protein palmitoylation and dynamic modulation of protein function. Curr Sci 2004, 87: 212-217